Norges Bank’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-42,672
| Closed | -$160K | – | 1913 |
|
|
2023
Q4 | $160K | Hold |
42,672
| – | – | ﹤0.01% | 1930 |
|
|
2023
Q3 | $90.5K | Sell |
42,672
-245,000
| -85% | -$519K | ﹤0.01% | 1960 |
|
|
2023
Q2 | $1.37M | Sell |
287,672
-666,867
| -70% | -$3.17M | ﹤0.01% | 1904 |
|
|
2023
Q1 | $5.44M | Buy |
954,539
+149,797
| +19% | +$854K | ﹤0.01% | 1731 |
|
|
2022
Q4 | $8.12M | Buy |
804,742
+99,728
| +14% | +$1.01M | ﹤0.01% | 1631 |
|
|
2022
Q3 | $15.8M | Hold |
705,014
| – | – | ﹤0.01% | 1332 |
|
|
2022
Q2 | $17.5M | Buy |
705,014
+146,386
| +26% | +$3.63M | ﹤0.01% | 1301 |
|
|
2022
Q1 | $21.7M | Sell |
558,628
-230,826
| -29% | -$8.95M | ﹤0.01% | 1362 |
|
|
2021
Q4 | $46.2M | Buy |
789,454
+25,625
| +3% | +$1.5M | 0.01% | 981 |
|
|
2021
Q3 | $45.3M | Buy |
763,829
+36,272
| +5% | +$2.15M | 0.01% | 975 |
|
|
2021
Q2 | $63.1M | Sell |
727,557
-92,848
| -11% | -$8.06M | 0.01% | 835 |
|
|
2021
Q1 | $67.6M | Sell |
820,405
-20,308
| -2% | -$1.67M | 0.02% | 802 |
|
|
2020
Q4 | $76.4M | Sell |
840,713
-33,201
| -4% | -$3.02M | 0.02% | 722 |
|
|
2020
Q3 | $34.9M | Buy |
873,914
+790,014
| +942% | +$31.6M | 0.01% | 1062 |
|
|
2020
Q2 | $2.88M | Buy |
+83,900
| New | +$2.88M | ﹤0.01% | 1930 |
|